Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04763902 · ClinicalTrials.gov registry record · NA
Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer
A NA study of Endometrial Neoplasms, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT04763902 is a NA study of Endometrial Neoplasms that has completed, run by University of Utah. The registered enrollment target is 17 participants, below the 375-participant average among 14 other Endometrial Neoplasms trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04763902, a NA study of Endometrial Neoplasms, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term goal of this study is to determine the efficacy of time restricted eating (TRE) for improving metabolic health and preventing endometrial cancer. The primary objective of the protocol is to conduct a 14-week two-arm randomized crossover trial of a dietary intervention to evaluate the feasibility, fidelity and preliminary acceptability of a TRE intervention among Native Hawaiian/Pacific Islander women at risk for developing endometrial cancer, and to provide proof of principle that TRE can improve metabolic health in this population.
Conditions Studied
Interventions
- BEHAVIORAL Time Restricted Eating (TRE) Schedule
Study Locations (1)
Utah
- Huntsman Cancer Institute - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-02-18 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04763902
The ClinicalTrials.gov registry entry for NCT04763902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 375-participant average among 14 other Endometrial Neoplasms trials with a reported enrollment target (95% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endometrial Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Time Restricted Eating (TRE) Schedule is the first listed.
NCT04763902 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT04763902 about?
NCT04763902 is a clinical study titled "Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer". The long-term goal of this study is to determine the efficacy of time restricted eating (TRE) for improving metabolic health and preventing endometrial cancer. The primary objective of the protocol is to conduct a 14-week two-arm randomized crossover trial of a dietary intervention to evaluate the f...
What is the current status of trial NCT04763902?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2021-02-18. Estimated completion is 2022-09-30.
What conditions does trial NCT04763902 study?
This clinical trial studies the following conditions: Endometrial Neoplasms.
What interventions are being tested in trial NCT04763902?
The interventions under investigation include: Time Restricted Eating (TRE) Schedule (BEHAVIORAL).
Who is sponsoring clinical trial NCT04763902?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04763902 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
COMPLETED · NA
-
A Study of LY4175408 in Participants With Advanced Cancer
RECRUITING · Phase 1
-
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RECRUITING · Phase 1
-
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
RECRUITING · Phase 1
-
A Study of DM002 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.